Aurora A kinase inhibition destabilizes PAX3-FOXO1 and MYCN and synergizes with Navitoclax to induce Rhabdomyosarcoma cell death

Journal: Cancer Research

Published: 2020-02-15

DOI: 10.1158/0008-5472.can-19-1479

Affiliations: 4

Authors: 13

Go to article
Institutions Share
Department of Oncology, University Children's Hospital of Zurich, Switzerland 0.46
ICR Division of Molecular Pathology, United Kingdom (UK) 0.23
Genetics and Biology of Cancers, France 0.15
Royal Manchester Children's Hospital, MFT, United Kingdom (UK) 0.15